1. Correlation between contrast-enhanced ultrasound findings and clinicopathological factors in breast cancer
    Masatoshi KADOYA et al, 2017, Jpn J Med Ultrasonics CrossRef
  2. Breast Biomarker Immunocytochemistry
    Soheila Korourian et al, 2018 CrossRef
  3. Comparison of Proliferation Markers Ki67 and Phosphohistone-H3 (pHH3) in Breast Ductal Carcinoma In Situ
    Dustin E. Bosch et al, 2017, Applied Immunohistochemistry & Molecular Morphology CrossRef
  4. ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis
    Diyu Wang et al, 2017, Tumour Biol. CrossRef
  5. Nonviral Gene Therapy for Cancer: A Review
    Chiaki Hidai et al, 2018, Diseases CrossRef
  6. Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer
    Jasmin Zeindler et al, 2019, Breast Cancer Res Treat CrossRef
  7. Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer
    Xiang Song et al, 2019 CrossRef
  8. Diagnostic ability of real-time quantitative polymerase chain reaction versus immunohistochemistry for Ki-67 assessment in breast cancer: An Indian perspective
    Anurag Mehta et al, 2019, Indian J Med Res CrossRef
  9. BI-RADS 3-5 microcalcifications: prediction of lymph node metastasis of breast cancer.
    Dongzhi Cen et al, 0 CrossRef
  10. Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway
    Xiaoyong Fan et al, 2018, Exp Ther Med CrossRef

  11. Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers


    Peng Jiang et al, 2020, CMAR CrossRef

  12. Prognostic Value of Ki67 in Patients with Stage 1–2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor


    Peng Jiang et al, 2020, OTT CrossRef
  13. The optimal cut‐off value of immunohistochemical parameter P53 for predicting recurrence of endometrial cancer
    Mingzhu Jia et al, 2020, Int J Gynecol Obstet CrossRef
  14. Associations of Estrogen Receptor, Progesterone Receptor, Human Epidemic Growth Factor Receptor-2 and Ki-67 with Ultrasound Signs and Prognosis of Breast Cancer Patients
    Xingjuan Zhao et al, 2021, CMAR CrossRef
  15. Analysis of Factors Related to Lymph Node Metastasis in Early-Stage Type 1 Endometrial Cancer: Verifying the Clinical Value of Positive Threshold of the Immunohistochemical Parameter Ki67
    Peng Jiang et al, 2021, CMAR CrossRef
  16. Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneity
    Anna Fomitcheva-Khartchenko et al, 2021, PLoS ONE CrossRef
  17. Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
    Yu Meng et al, 2022, Front. Med. CrossRef
  18. Lipopolyplex-based delivery system for cancer vaccine delivery
    Jasmeet Kaur et al, 2022 CrossRef
  19. Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer
    Ning Li et al, 2022, Clin Med Insights Oncol CrossRef
  20. Прогностическая и предиктивная значимость маркера Ki67 при раке молочной железы
    И. М. Тележникова et al, 2022, Zlokač. opuholi CrossRef
  21. Markers associated with genomic instability, immunogenicity and immune therapy responsiveness in Metaplastic carcinoma of the breast: Expression of γH2AX, pRPA2, P53, PD-L1 and tumor infiltrating lymphocytes in 76 cases
    S. Voutilainen et al, 2022, BMC Cancer CrossRef
  22. A Winning New Combination? Toward Clinical Application in Oncology
    Quratulain Maqsood et al, 2023, Cancer Control CrossRef
  23. Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experience
    Wang Li et al, 2023, J Int Med Res CrossRef